Moving Life Science Innovations along the path
From Discovery To Development To Delivery

OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

Arizona’s bioscience industry employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. Academic R&D expenditures in bioscience fields reached a new height of $683.3 million in 2022. NIH funding for Arizona totaled $366.5 million in 2023 following steady annual growth since 2019. Arizona’s bioscience companies attracted strong venture capital investment, with $281.8 million invested in 2023. Arizona stands out in patent activity in bioscience-related technology areas—its 3,387 patent awards from 2019 through 2023 places the state in the second quintile among all states.  AZ-BIO2024 - state profile

IN THE LOOP

AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.

Subscribe

AZBio Members Are Making LIFE Better

AZBio Members discover, develop, and deliver life-saving and life-changing innovations.

Premiere Supporters

Leadership Supporters

Sustaining Members

Get Connected With Arizona's Bioindustry

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.  

AZBio  Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector.  As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

Success Stories – Good News from Arizona’s BioIndustry

Whole-Person Genomics: New Partnership Tackles Rare Disease and Serious Mental Illness by Linking DNA Insights with Community Social Support Networks

TUCSON, AZ – UGenome AI, a pioneer in genomic technology, today announced an expanded partnership with Jura Health, Inc. to integrate both pharmacogenomic and nutrigenomic insights into the diagnosis of rare diseases and the development of personalized care plans. By combining expertise in whole genome sequencing (WGS), drug-gene interactions, and nutrient- gene relationships, the collaboration is designed to help rare disease patients receive […]

Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders

SAN FRANCISCO and TUCSON, Ariz., May 29, 2025 — Critical Path Institute® (C-Path), a global nonprofit accelerating drug development through data science and regulatory innovation, and Citizen Health, a leading consumer health platform, today announced their new strategic collaboration. Together, the organizations will establish a partnership focused on neuromuscular disorders, including limb-girdle muscular dystrophies (LGMDs), […]

CEO Forums: An FDA Listening Tour to Engage Pharma CEOs

The U.S. Food and Drug Administration is conducting a national listening tour to meet directly with pharmaceutical and biotech CEOs. Held in major innovation hubs across the country, the CEO Forums will be led by FDA Commissioner Marty A. Makary, M.D., M.P.H., along with Principal Deputy Commissioner Sara Brenner, M.D., M.P.H and Director of FDA’s […]

ASU partners with biotech luminary and alum Mark McKenna to launch preeminent life science business program

Future health care leaders and innovators will accelerate their path through the McKenna Life Sciences, Business and Entrepreneurship Program, enabling the next generation of biotech game changers. A cross-college collaboration between the W. P. Carey School of Business and The College of Liberal Arts and Sciences, the program reflects ASU’s decade-long status as America’s most innovative university. […]

Events

AZBio Builds Relationships With Partners Across The Country

Partner Opportunities for AZBio Members